CRH (CRH) Financials

$107.68 -1.07 (-0.98%)

Closing price 03:59 PM Eastern

Extended Trading

$111.50 +3.82 (+3.55%)

As of 07:58 PM Eastern

Annual Income Statements for CRH

This table shows CRH's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	685	1,280	2,240	2,889	-	1,304	2,630	3,862	3,178	3,492	3,753
Consolidated Net Income / (Loss)	792	1,336	2,305	2,889	1,738	1,165	2,686	3,889	3,072	3,521	3,790
Net Income / (Loss) Continuing Operations	700	1,251	2,010	1,526	-	1,009	2,507	2,699	3,072	3,521	3,790
Total Pre-Tax Income	1,000	1,704	2,024	1,993	-	1,454	3,102	3,461	4,014	4,714	4,805
Total Operating Income	1,267	2,007	2,315	2,446	-	2,026	3,327	3,809	4,186	4,925	5,440
Total Gross Profit	7,240	8,651	8,863	9,058	9,273	8,565	9,827	10,815	11,963	12,701	13,528
Total Revenue	23,259	26,078	26,011	27,424	-	25,888	29,206	32,723	34,949	35,572	37,447
Operating Revenue	23,259	26,078	26,011	27,424	-	25,888	29,206	32,723	34,949	35,572	37,447
Total Cost of Revenue	16,019	17,427	17,148	18,391	-	17,323	19,379	21,908	22,986	22,871	23,919
Operating Cost of Revenue	16,019	17,427	17,148	18,391	-	17,323	19,379	21,908	22,986	22,871	23,919
Total Operating Expenses	5,973	6,643	6,548	6,612	-	6,539	6,500	7,006	7,777	7,776	8,088
Selling, General & Admin Expense	-	-	-	-	-	-	6,538	7,056	7,486	7,852	8,283
Impairment Charge	-	-	-	-	-	-	0.00	0.00	357	161	40
Other Special Charges / (Income)	-	-	-	-	-	-	-38	-50	-66	-237	-235
Total Other Income / (Expense), net	-375	-359	-356	-453	-	-589	-225	-348	-172	-211	-635
Interest Expense	431	411	362	-	-	438	315	344	376	612	810
Interest & Investment Income	8.69	8.42	14	-	-	0.00	0.00	65	206	143	146
Other Income / (Expense), net	48	44	-8.41	-453	-	-151	90	-69	-2.00	258	29
Income Tax Expense	300	453	14	467	-	445	650	762	925	1,085	1,041
Other Gains / (Losses), net	-	-	-	-	-	-	55	0.00	-17	-108	26
Net Income / (Loss) Attributable to Noncontrolling Interest	-	-	-	-	-	-	56	27	-106	29	37
Basic Earnings per Share	$0.89	$1.50	$2.72	-	-	$1.43	$3.35	$5.15	$4.36	$5.06	$5.54
Weighted Average Basic Shares Outstanding	-	-	838.96M	843.39M	799.64M	795.14M	780.20M	758.30M	723.90M	683.30M	673.20M
Diluted Earnings per Share	$0.89	$1.49	$2.71	-	-	$1.42	$3.32	$5.11	$4.33	$5.02	$5.51
Weighted Average Diluted Shares Outstanding	-	-	838.96M	843.39M	799.64M	795.14M	786.80M	764.10M	729.20M	689.50M	677M
Weighted Average Basic & Diluted Shares Outstanding	-	-	838.96M	843.39M	799.64M	795.14M	774.14M	752.14M	690.36M	676.48M	668.25M
Cash Dividends to Common per Share	-	-	-	-	-	-	$1.21	$1.27	$1.33	$1.40	$1.48

This table shows CRH's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	1,306	701	116	1,297	1,376	703	-94	1,319	1,503	1,025	-176
Consolidated Net Income / (Loss)	1,318	573	114	1,309	1,389	709	-98	1,332	1,519	1,037	-180
Net Income / (Loss) Continuing Operations	1,318	573	114	1,309	1,389	709	-98	1,332	1,519	1,037	-180
Total Pre-Tax Income	1,720	755	99	1,733	1,895	987	-146	1,756	1,921	1,274	-224
Total Operating Income	1,788	783	28	1,829	1,964	1,104	18	1,935	2,081	1,406	-38
Total Gross Profit	3,763	2,951	1,807	3,675	4,059	3,160	1,837	4,026	4,309	3,356	2,045
Total Revenue	10,128	8,685	6,533	9,654	10,515	8,870	6,756	10,206	11,069	9,416	7,370
Operating Revenue	10,128	8,685	6,533	9,654	10,515	8,870	6,756	10,206	11,069	9,416	7,370
Total Cost of Revenue	6,365	5,734	4,726	5,979	6,456	5,710	4,919	6,180	6,760	6,060	5,325
Operating Cost of Revenue	6,365	5,734	4,726	5,979	6,456	5,710	4,919	6,180	6,760	6,060	5,325
Total Operating Expenses	1,975	2,168	1,779	1,846	2,095	2,056	1,819	2,091	2,228	1,950	2,083
Selling, General & Admin Expense	1,990	1,839	1,787	1,948	2,184	1,933	1,833	2,120	2,338	1,992	2,057
Impairment Charge	-	-	-	-	-	-	0.00	-	-	-	48
Other Special Charges / (Income)	-15	-28	-8.00	-102	-89	-38	-14	-29	-110	-82	-22
Total Other Income / (Expense), net	-68	-28	71	-96	-69	-117	-164	-179	-160	-132	-186
Interest Expense	131	91	133	155	164	160	181	200	209	220	203
Interest & Investment Income	62	68	43	36	33	31	37	30	37	42	21
Other Income / (Expense), net	1.00	-5.00	161	23	62	12	-20	-9.00	12	46	-4.00
Income Tax Expense	416	144	-19	430	531	143	-58	425	428	246	-55
Other Gains / (Losses), net	14	-38	-4.00	6.00	25	-135	-10	1.00	26	9.00	-11
Net Income / (Loss) Attributable to Noncontrolling Interest	12	-128	-2.00	12	13	6.00	-4.00	13	16	12	-4.00
Basic Earnings per Share	$1.81	$0.97	$0.16	$1.89	$1.99	$1.02	($0.15)	$1.95	$2.23	$1.51	($0.27)
Weighted Average Basic Shares Outstanding	718.20M	723.90M	687.80M	685.50M	681.60M	683.30M	676.70M	674.80M	672.30M	673.20M	668.50M
Diluted Earnings per Share	$1.80	$0.96	$0.16	$1.88	$1.97	$1.01	($0.15)	$1.94	$2.21	$1.51	($0.27)
Weighted Average Diluted Shares Outstanding	722.10M	729.20M	693.40M	688.80M	685.50M	689.50M	676.70M	677.70M	675.50M	677M	668.50M
Weighted Average Basic & Diluted Shares Outstanding	-	690.36M	686.68M	682.78M	679.34M	676.48M	676.00M	672.66M	670.27M	668.25M	668.20M
Cash Dividends to Common per Share	$0.25	-	$0.35	-	-	-	$0.37	-	-	-	$0.39

This table details how cash moves in and out of CRH's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-4,181	-4,133	-5,388	-5,946	1,552	3,466	-1,938	153	454	-2,631	388
Net Cash From Operating Activities	1,057	-1,510	-2,392	-3,885	3,881	4,116	3,979	3,800	5,017	4,989	5,625
Net Cash From Continuing Operating Activities	1,057	-1,510	-2,392	-3,885	2,580	4,116	3,979	3,800	5,017	4,989	5,625
Net Income / (Loss) Continuing Operations	0.00	0.00	0.00	0.00	2,181	1,165	2,686	3,889	3,072	3,521	3,790
Consolidated Net Income / (Loss)	-	-	-	-	2,181	1,165	2,686	3,889	3,072	3,521	3,790
Depreciation Expense	916	1,061	1,208	1,265	1,721	1,624	1,551	1,577	1,633	1,798	2,156
Non-Cash Adjustments To Reconcile Net Income	205	-2,511	-3,285	-4,539	-1,024	1,185	27	-1,242	547	-14	-84
Changes in Operating Assets and Liabilities, net	-64	-60	-315	-611	-364	142	-285	-424	-235	-316	-237
Net Cash From Investing Activities	-8,886	-1,054	-3,466	-5,400	217	-1,347	-2,513	-917	-2,391	-6,291	-6,045
Net Cash From Continuing Investing Activities	-8,886	-1,054	-3,466	-5,400	-2,040	-1,347	-2,513	-917	-2,391	-6,291	-6,045
Purchase of Property, Plant & Equipment	-	-	-1,254	-1,324	-1,374	-996	-1,554	-1,523	-1,817	-2,578	-2,713
Acquisitions	-	-	-2,211	-4,076	-727	-351	-1,494	-3,253	-640	-4,900	-3,856
Purchase of Investments	-	-	-	-	-	-	0.00	-11	-1.00	-9.00	-81
Sale of Property, Plant & Equipment	-958	-897	-	-	-	-	387	115	104	272	315
Divestitures	-7,927	-157	-	-	-	-	120	3,712	0.00	1,001	139
Sale and/or Maturity of Investments	-	-	-	-	39	-	32	36	44	44	50
Other Investing Activities, net	-	-	-	-	22	-	-4.00	7.00	-81	-121	101
Net Cash From Financing Activities	3,648	-1,570	470	3,339	2,546	697	-3,107	-2,499	-2,380	-1,186	596
Net Cash From Continuing Financing Activities	3,648	-1,570	470	3,339	-2,485	697	-3,107	-2,499	-2,380	-1,186	596
Repayment of Debt	-41	0.00	-434	-291	-996	-4,943	-1,183	-364	-1,462	-1,859	-7,612
Repurchase of Common Equity	-	-	-3.60	-921	-954	-249	-896	-1,178	-3,067	-1,482	-1,181
Payment of Dividends	-416	-379	-573	-633	-663	-722	-946	-943	-977	-1,740	-1,002
Issuance of Debt	4,105	-1,191	1,480	5,184	106	6,611	0.00	38	3,163	4,001	10,479
Other Financing Activities, net	-	-	-	-	22	-	-82	-52	-37	-106	-88
Effect of Exchange Rate Changes	-	-	-	-	-	-	-297	-231	208	-143	212
Cash Interest Paid	328	364	381	394	-	432	340	329	418	599	724
Cash Income Taxes Paid	-	-	-	-	-	-	642	1,043	959	960	831

This table details how cash moves in and out of CRH's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	1,447	668	-3,081	637	-866	679	-407	-476	1,412	-141	-814
Net Cash From Operating Activities	1,631	2,423	-712	1,485	1,486	2,730	-659	1,378	1,991	2,915	-616
Net Cash From Continuing Operating Activities	1,631	2,423	-712	1,485	1,486	2,730	-659	1,378	1,991	2,915	-616
Net Income / (Loss) Continuing Operations	1,318	573	114	1,309	1,389	709	-98	1,332	1,519	1,037	-180
Consolidated Net Income / (Loss)	1,318	573	114	1,309	1,389	709	-98	1,332	1,519	1,037	-180
Depreciation Expense	402	446	397	424	467	510	477	528	601	550	576
Amortization Expense	-	-	-	-	-	-	-	-	-	-	83
Non-Cash Adjustments To Reconcile Net Income	16	451	-105	-80	-155	326	16	42	-93	-49	-85
Changes in Operating Assets and Liabilities, net	-105	953	-1,118	-168	-215	1,185	-1,054	-524	-36	1,377	-1,010
Net Cash From Investing Activities	-759	-662	-2,096	-521	-1,788	-1,886	-964	-831	-2,910	-1,340	-722
Net Cash From Continuing Investing Activities	-759	-668	-2,096	-521	-1,788	-1,886	-964	-831	-2,910	-1,340	-722
Purchase of Property, Plant & Equipment	-404	-642	-506	-624	-505	-943	-645	-655	-592	-821	-601
Acquisitions	-363	-79	-2,206	-316	-1,331	-1,047	-585	-63	-2,473	-735	-126
Purchase of Investments	-4.00	-4.00	-13	10	-18	12	20	-53	-39	-9.00	-24
Sale of Property, Plant & Equipment	22	40	10	357	84	-908	35	30	118	132	28
Divestitures	5.00	-5.00	729	-	27	919	36	1.00	15	87	6.00
Sale and/or Maturity of Investments	11	21	6.00	9.00	7.00	22	9.00	4.00	10	27	0.00
Other Investing Activities, net	-26	1.00	-116	-12	-52	59	166	-95	51	-21	-5.00
Net Cash From Financing Activities	649	-1,283	-176	-339	-629	-42	1,141	-1,153	2,331	-1,723	572
Net Cash From Continuing Financing Activities	649	-1,281	-176	-339	-629	-42	1,141	-1,153	2,331	-1,723	570
Repayment of Debt	-91	-522	-651	-1,040	-163	-5.00	-1,533	-1,819	-345	-3,915	-207
Repurchase of Common Equity	-1,072	-1,036	-559	-348	-317	-258	-310	-334	-286	-251	-332
Payment of Dividends	-12	-179	-767	-486	-249	-238	-17	-503	-258	-224	-39
Issuance of Debt	1,832	476	1,818	1,552	82	549	3,017	1,525	3,218	2,719	1,212
Other Financing Activities, net	-8.00	-20	-17	-17	18	-90	-16	-22	2.00	-52	-64
Effect of Exchange Rate Changes	-74	190	-97	12	65	-123	75	130	-	7.00	-48
Cash Interest Paid	43	174	45	171	156	227	63	188	243	230	160
Cash Income Taxes Paid	343	339	159	145	350	306	134	170	76	451	39

This table presents CRH's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	33,237	37,999	46,777	47,612	44,944	44,670	45,319	47,469	50,613	58,329
Total Current Assets	9,882	11,737	17,395	17,258	14,977	14,044	14,833	16,885	14,083	15,254
Cash & Equivalents	2,576	2,541	9,191	9,918	7,721	5,783	5,936	6,341	3,720	4,096
Restricted Cash	-	-	-	-	-	-	-	0.00	39	51
Accounts Receivable	4,186	4,361	4,665	4,231	4,086	4,569	4,300	4,507	4,820	5,178
Inventories, net	3,092	3,261	3,505	3,080	3,117	3,611	4,194	4,291	4,755	5,251
Other Current Assets	-	-	-	-	-	-	403	478	749	678
Other Current Nonoperating Assets	-	-	-	-	-	-	-	1,268	-	0.00
Plant, Property, & Equipment, net	13,350	15,729	18,046	19,574	19,317	19,502	17,768	17,841	21,452	24,937
Total Noncurrent Assets	10,005	10,533	11,336	10,780	10,650	11,124	12,718	12,743	15,078	18,138
Long-Term Investments	1,367	1,499	1,332	775	626	653	649	620	737	502
Goodwill	-	-	-	-	-	-	9,199	9,158	11,061	13,099
Intangible Assets	8,165	8,666	9,656	9,475	9,373	9,848	1,088	1,041	1,211	2,048
Other Noncurrent Operating Assets	83	66	60	98	197	275	1,782	1,924	2,069	2,489
Total Liabilities & Shareholders' Equity	33,237	37,999	46,777	47,612	44,944	44,670	45,319	47,469	50,613	58,329
Total Liabilities	18,043	20,008	27,825	27,977	24,596	23,756	22,279	25,848	27,763	32,851
Total Current Liabilities	6,690	7,516	14,006	13,411	7,465	7,581	8,041	10,013	10,296	8,754
Short-Term Debt	289	380	7,213	6,616	1,257	549	1,491	1,866	2,999	1,175
Accounts Payable	5,550	5,718	5,817	5,461	5,503	6,409	2,930	3,149	3,207	3,263
Accrued Expenses	-	-	-	-	-	-	2,132	2,296	2,248	2,196
Other Current Liabilities	436	869	468	769	797	790	1,488	2,327	1,842	2,120
Other Current Nonoperating Liabilities	-	-	-	-	-	-	0.00	375	-	0.00
Total Noncurrent Liabilities	11,353	12,492	13,819	14,566	17,131	16,175	14,238	15,835	17,467	24,097
Long-Term Debt	7,906	9,202	9,959	9,211	10,958	9,938	8,145	9,776	10,969	16,478
Noncurrent Deferred & Payable Income Tax Liabilities	2,112	2,001	2,530	2,627	2,613	2,734	2,885	2,738	3,105	3,511
Other Noncurrent Operating Liabilities	713	836	844	855	954	937	3,208	3,321	3,393	4,108
Commitments & Contingencies	-	-	-	-	-	-	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	-	-	-	-	-	-	308	333	384	430
Total Equity & Noncontrolling Interests	15,193	17,990	18,951	19,634	20,347	20,914	22,732	21,288	22,466	25,048
Total Preferred & Common Equity	14,616	17,406	18,349	19,027	40,004	20,233	22,157	20,854	21,607	24,004
Preferred Stock	-	-	-	-	7,493	-	1.00	1.00	1.00	1.00
Total Common Equity	14,616	17,406	18,349	19,027	12,162	20,232	22,156	20,853	21,606	24,003
Common Stock	299	344	352	335	333	309	745	750	712	683
Retained Earnings	6,809	9,493	11,705	11,350	11,565	19,770	22,495	22,918	24,036	25,593
Treasury Stock	-15	-18	-920	-360	-386	-195	-297	-2,199	-2,137	-2,016
Accumulated Other Comprehensive Income / (Loss)	-	-	-	-	-	-	-787	-616	-1,005	-257
Noncontrolling Interest	576	584	602	607	692	681	575	434	859	1,044

This table presents CRH's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	45,107	46,142	47,631	46,333	48,105	51,221	51,921	53,984	58,527	58,167
Total Current Assets	14,230	15,074	16,315	13,709	15,113	14,840	14,242	15,151	16,852	16,239
Cash & Equivalents	4,650	4,275	5,722	3,308	3,066	2,978	3,352	2,876	4,198	3,240
Restricted Cash	-	0.00	0.00	0.00	869	102	0.00	0.00	90	40
Accounts Receivable	4,706	6,119	5,972	4,798	5,893	6,422	5,141	6,490	6,961	5,213
Inventories, net	4,458	4,276	4,191	4,619	4,514	4,644	4,960	5,051	5,019	5,058
Other Current Assets	416	404	430	748	704	694	789	734	584	877
Other Current Nonoperating Assets	0.00	0.00	0.00	236	67	-	0.00	0.00	-	1,811
Plant, Property, & Equipment, net	17,997	18,155	18,103	18,878	19,235	21,289	22,179	23,017	23,783	24,657
Total Noncurrent Assets	12,880	12,913	13,213	13,746	13,757	15,092	15,500	15,816	17,892	17,271
Long-Term Investments	655	672	665	609	484	929	732	712	743	487
Goodwill	9,308	9,338	9,545	10,125	10,251	10,906	11,475	11,673	12,676	12,592
Intangible Assets	1,094	1,061	1,074	1,093	1,086	1,105	1,208	1,239	2,146	1,956
Other Noncurrent Operating Assets	1,823	1,842	1,929	1,919	1,936	2,152	2,085	2,192	2,327	2,236
Total Liabilities & Shareholders' Equity	45,107	46,142	47,631	46,333	48,105	51,221	51,921	53,984	58,527	58,167
Total Liabilities	22,963	23,433	24,983	25,591	26,654	28,055	29,564	30,354	33,898	33,622
Total Current Liabilities	9,255	9,671	9,191	9,997	10,548	10,668	8,712	8,684	11,596	10,211
Short-Term Debt	2,251	2,185	1,860	2,992	3,218	3,218	1,458	1,171	3,968	2,478
Accounts Payable	2,627	3,553	2,954	2,730	3,363	2,963	2,777	3,303	3,156	2,947
Accrued Expenses	2,079	2,335	2,457	2,241	2,272	2,513	2,270	2,266	2,393	2,143
Other Current Liabilities	2,298	1,598	1,920	1,990	1,681	1,974	2,207	1,944	2,079	2,215
Other Current Nonoperating Liabilities	0.00	0.00	0.00	44	14	-	0.00	0.00	-	428
Total Noncurrent Liabilities	13,708	13,762	15,792	15,594	16,106	17,387	20,852	21,670	22,302	23,411
Long-Term Debt	7,583	7,563	9,535	9,680	9,900	10,672	14,213	14,642	14,734	16,071
Noncurrent Deferred & Payable Income Tax Liabilities	2,972	3,010	3,050	2,684	2,914	3,168	3,141	3,202	3,595	3,301
Other Noncurrent Operating Liabilities	3,153	3,189	3,207	3,230	3,292	3,547	3,498	3,826	3,973	4,039
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	307	313	320	326	335	361	379	389	419	422
Total Equity & Noncontrolling Interests	21,837	22,396	22,328	20,416	21,116	22,805	21,978	23,241	24,210	24,123
Total Preferred & Common Equity	21,255	21,821	21,767	20,015	20,726	21,875	21,119	22,345	23,309	23,071
Preferred Stock	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00
Total Common Equity	21,254	21,820	21,766	20,014	20,725	21,874	21,118	22,344	23,308	23,070
Common Stock	722	693	725	631	651	683	587	611	648	535
Retained Earnings	21,692	22,892	23,936	22,346	23,030	23,831	23,375	24,106	25,068	24,793
Treasury Stock	-487	-1,140	-2,132	-2,166	-2,143	-2,141	-2,038	-2,028	-2,027	-1,905
Accumulated Other Comprehensive Income / (Loss)	-673	-625	-763	-797	-813	-499	-806	-345	-381	-353
Noncontrolling Interest	582	575	561	401	390	930	859	896	901	1,052

This table displays calculated financial ratios and metrics derived from CRH's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	12.12%	-0.26%	5.43%	0.00%	0.00%	12.82%	12.04%	6.80%	1.78%	5.27%
EBITDA Growth	0.00%	39.55%	12.91%	-9.14%	-45.15%	95.80%	41.98%	7.03%	9.40%	20.01%	9.23%
EBIT Growth	0.00%	56.03%	12.43%	-16.16%	-100.00%	0.00%	82.24%	9.45%	11.87%	23.88%	5.52%
NOPAT Growth	0.00%	66.12%	56.01%	-18.51%	-100.00%	0.00%	87.05%	12.95%	8.45%	17.70%	12.40%
Net Income Growth	0.00%	68.67%	72.54%	25.33%	-39.84%	-32.97%	130.56%	44.79%	-21.01%	14.62%	7.64%
EPS Growth	0.00%	68.09%	81.60%	0.00%	0.00%	0.00%	133.80%	53.92%	-15.26%	15.94%	9.76%
Operating Cash Flow Growth	0.00%	-242.79%	-58.43%	-62.44%	199.90%	6.06%	-3.33%	-4.50%	32.03%	-0.56%	12.75%
Free Cash Flow Firm Growth	0.00%	0.00%	97.57%	-257.21%	63.29%	454.28%	-7.67%	70.22%	22.77%	-179.97%	39.18%
Invested Capital Growth	0.00%	0.00%	14.08%	15.47%	2.23%	-2.36%	2.98%	-0.79%	-2.61%	27.21%	19.06%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.52%	1.48%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	6.11%	5.19%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	6.98%	6.55%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	8.69%	4.67%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	4.02%	9.47%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.01%	9.98%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	6.56%	3.40%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-60.66%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-2.19%	0.48%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	31.13%	33.17%	34.07%	33.03%	0.00%	33.08%	33.65%	33.05%	34.23%	35.71%	36.13%
EBITDA Margin	9.59%	11.94%	13.51%	11.88%	0.00%	13.52%	17.01%	16.25%	16.64%	19.63%	20.36%
Operating Margin	5.45%	7.70%	8.90%	8.92%	0.00%	7.83%	11.39%	11.64%	11.98%	13.85%	14.53%
EBIT Margin	5.65%	7.87%	8.87%	7.27%	0.00%	7.24%	11.70%	11.43%	11.97%	14.57%	14.60%
Profit (Net Income) Margin	3.41%	5.12%	8.86%	10.53%	0.00%	4.50%	9.20%	11.88%	8.79%	9.90%	10.12%
Tax Burden Percent	79.24%	78.40%	113.89%	144.96%	0.00%	80.12%	86.59%	112.37%	76.53%	74.69%	78.88%
Interest Burden Percent	76.03%	83.08%	87.76%	100.00%	0.00%	77.55%	90.78%	92.54%	95.94%	90.95%	87.86%
Effective Tax Rate	30.00%	26.60%	0.71%	23.43%	0.00%	30.61%	20.95%	22.02%	23.04%	23.02%	21.66%
Return on Invested Capital (ROIC)	0.00%	15.17%	11.06%	7.85%	0.00%	5.44%	10.15%	11.34%	12.51%	13.13%	12.04%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	8.68%	11.22%	26.67%	0.00%	1.33%	11.21%	33.12%	8.14%	9.06%	7.84%
Return on Net Nonoperating Assets (RNNOA)	0.00%	2.42%	2.84%	7.80%	0.00%	0.39%	2.87%	6.36%	1.25%	2.70%	3.65%
Return on Equity (ROE)	0.00%	17.59%	13.89%	15.64%	9.01%	5.83%	13.02%	17.70%	13.76%	15.84%	15.68%
Cash Return on Invested Capital (CROIC)	0.00%	-184.83%	-2.09%	-6.52%	-2.21%	7.83%	7.21%	12.14%	15.16%	-10.81%	-5.36%
Operating Return on Assets (OROA)	0.00%	6.17%	6.48%	4.70%	0.00%	4.05%	7.63%	8.31%	9.02%	10.57%	10.04%
Return on Assets (ROA)	0.00%	4.02%	6.47%	6.82%	0.00%	2.52%	5.99%	8.64%	6.62%	7.18%	6.96%
Return on Common Equity (ROCE)	0.00%	16.92%	13.41%	15.14%	8.73%	4.55%	10.22%	17.07%	13.25%	15.12%	14.80%
Return on Equity Simple (ROE_SIMPLE)	0.00%	9.14%	13.24%	15.74%	9.13%	2.91%	13.28%	17.55%	14.73%	16.30%	0.00%
Net Operating Profit after Tax (NOPAT)	887	1,473	2,298	1,873	0.00	1,406	2,630	2,970	3,221	3,791	4,261
NOPAT Margin	3.81%	5.65%	8.84%	6.83%	0.00%	5.43%	9.00%	9.08%	9.22%	10.66%	11.38%
Net Nonoperating Expense Percent (NNEP)	0.00%	6.49%	-0.16%	-18.82%	-26.43%	4.11%	-1.06%	-21.78%	4.37%	4.08%	4.19%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	9.18%	9.78%	10.41%	9.98%
Cost of Revenue to Revenue	68.87%	66.83%	65.93%	67.06%	0.00%	66.92%	66.35%	66.95%	65.77%	64.30%	63.87%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	22.39%	21.56%	21.42%	22.07%	22.12%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	25.68%	25.48%	25.17%	24.11%	0.00%	25.26%	22.26%	21.41%	22.25%	21.86%	21.60%
Earnings before Interest and Taxes (EBIT)	1,315	2,051	2,306	1,993	0.00	1,875	3,417	3,740	4,184	5,183	5,469
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	2,231	3,113	3,515	3,258	1,787	3,499	4,968	5,317	5,817	6,981	7,625
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	1.09	1.65	2.68	2.03	1.30	2.46	2.91	3.49
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	2.29	3.29	11.67	3.96	2.43	4.81	6.73	9.45
Price to Revenue (P/Rev)	0.00	0.00	0.00	0.73	0.00	1.26	1.41	0.88	1.46	1.77	2.23
Price to Earnings (P/E)	0.00	0.00	0.00	6.90	0.00	24.95	15.65	7.46	16.11	18.00	22.29
Dividend Yield	2.84%	2.38%	2.27%	3.41%	2.15%	2.23%	2.26%	0.00%	1.95%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	14.48%	0.00%	4.01%	6.39%	13.41%	6.21%	5.56%	4.49%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	1.06	1.48	1.80	1.80	1.25	2.23	2.28	2.55
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.99	0.00	1.77	1.62	1.00	1.62	2.07	2.62
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	8.34	21.60	13.12	9.51	6.16	9.74	10.54	12.87
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	13.64	0.00	24.49	13.82	8.75	13.54	14.19	17.94
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	14.51	0.00	32.65	17.96	11.02	17.58	19.40	23.03
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	9.95	11.15	11.87	8.62	11.29	14.75	17.45
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	22.69	25.28	10.30	14.51	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.54	0.53	0.91	0.88	0.67	0.57	0.42	0.54	0.61	0.69
Long-Term Debt to Equity	0.00	0.52	0.51	0.53	0.54	0.60	0.54	0.35	0.45	0.48	0.65
Financial Leverage	0.00	0.28	0.25	0.29	0.34	0.29	0.26	0.19	0.15	0.30	0.47
Leverage Ratio	0.00	2.19	2.15	2.29	2.45	2.32	2.17	2.05	2.08	2.21	2.25
Compound Leverage Factor	0.00	1.82	1.88	2.29	0.00	1.80	1.97	1.89	1.99	2.01	1.98
Debt to Total Capital	0.00%	35.04%	34.75%	47.54%	46.72%	39.98%	36.19%	29.49%	35.00%	37.94%	40.93%
Short-Term Debt to Total Capital	0.00%	1.24%	1.38%	19.97%	17.95%	3.71%	1.68%	4.56%	5.61%	8.15%	2.72%
Long-Term Debt to Total Capital	0.00%	33.80%	33.37%	27.57%	28.77%	36.27%	34.51%	24.93%	29.39%	29.79%	38.20%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	22.10%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	2.46%	2.12%	1.67%	1.65%	2.04%	2.08%	2.70%	2.31%	3.38%	3.42%
Common Equity to Total Capital	0.00%	62.50%	63.13%	50.80%	51.63%	35.88%	61.73%	67.81%	62.69%	58.68%	55.65%
Debt to EBITDA	0.00	2.63	2.73	5.27	9.64	3.87	2.39	1.81	2.00	2.00	2.32
Net Debt to EBITDA	0.00	1.36	1.56	2.04	3.65	1.48	1.08	0.57	0.80	1.36	1.71
Long-Term Debt to EBITDA	0.00	2.54	2.62	3.06	5.93	3.51	2.28	1.53	1.68	1.57	2.16
Debt to NOPAT	0.00	5.56	4.17	9.17	0.00	9.64	4.51	3.24	3.61	3.68	4.14
Net Debt to NOPAT	0.00	2.87	2.39	3.54	0.00	3.69	2.05	1.03	1.45	2.50	3.05
Long-Term Debt to NOPAT	0.00	5.37	4.00	5.32	0.00	8.75	4.30	2.74	3.03	2.89	3.87
Altman Z-Score	0.00	0.00	0.00	1.59	1.11	2.07	2.74	2.64	3.07	3.15	3.23
Noncontrolling Interest Sharing Ratio	0.00%	3.79%	3.50%	3.21%	3.13%	21.99%	21.49%	3.56%	3.70%	4.52%	5.63%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.00	1.48	1.56	1.24	1.29	2.01	1.85	1.84	1.69	1.37	1.74
Quick Ratio	0.00	1.01	0.92	0.99	1.06	1.58	1.37	1.27	1.08	0.83	1.06
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-17,949	-435	-1,555	-571	2,023	1,868	3,179	3,903	-3,122	-1,899
Operating Cash Flow to CapEx	110.32%	-168.23%	-190.71%	-293.43%	282.46%	413.25%	340.96%	269.89%	292.88%	216.35%	234.57%
Free Cash Flow to Firm to Interest Expense	0.00	-43.64	-1.20	0.00	0.00	4.62	5.93	9.24	10.38	-5.10	-2.34
Operating Cash Flow to Interest Expense	2.45	-3.67	-6.61	0.00	0.00	9.40	12.63	11.05	13.34	8.15	6.94
Operating Cash Flow Less CapEx to Interest Expense	0.23	-5.85	-10.08	0.00	0.00	7.12	8.93	6.95	8.79	4.38	3.98
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.78	0.73	0.65	0.00	0.56	0.65	0.73	0.75	0.73	0.69
Accounts Receivable Turnover	0.00	6.23	6.09	6.08	0.00	6.23	6.75	7.38	7.94	7.63	7.49
Inventory Turnover	0.00	5.64	5.40	5.44	0.00	5.59	5.76	5.61	5.42	5.06	4.78
Fixed Asset Turnover	0.00	1.95	1.79	1.62	0.00	1.33	1.50	1.76	1.96	1.81	1.61
Accounts Payable Turnover	0.00	3.14	3.04	3.19	0.00	3.16	3.25	4.69	7.56	7.20	7.39
Days Sales Outstanding (DSO)	0.00	58.59	59.97	60.06	0.00	58.63	54.08	49.46	45.99	47.85	48.73
Days Inventory Outstanding (DIO)	0.00	64.76	67.62	67.15	0.00	65.29	63.36	65.02	67.37	72.18	76.35
Days Payable Outstanding (DPO)	0.00	116.25	119.93	114.46	0.00	115.51	112.18	77.80	48.26	50.72	49.37
Cash Conversion Cycle (CCC)	0.00	7.10	7.66	12.74	0.00	8.41	5.26	36.68	65.09	69.32	75.71
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	0.00	19,422	22,156	25,584	26,155	25,538	26,300	26,091	25,409	32,322	38,482
Invested Capital Turnover	0.00	2.69	1.25	1.15	0.00	1.00	1.13	1.25	1.36	1.23	1.06
Increase / (Decrease) in Invested Capital	0.00	19,422	2,734	3,428	571	-617	762	-209	-682	6,913	6,160
Enterprise Value (EV)	0.00	0.00	0.00	27,179	38,598	45,909	47,228	32,740	56,643	73,568	98,129
Market Capitalization	0.00	0.00	0.00	19,945	31,471	32,534	41,161	28,805	51,194	62,852	83,650
Book Value per Share	$0.00	$0.00	$20.75	$21.87	$22.56	$15.21	$25.44	$29.22	$27.72	$31.80	$35.81
Tangible Book Value per Share	$0.00	$0.00	$10.42	$10.36	$11.33	$3.49	$13.06	$15.65	$14.16	$13.74	$13.21
Total Capital	0.00	23,388	27,571	36,123	36,854	33,901	32,775	32,676	33,263	36,818	43,131
Total Debt	0.00	8,195	9,581	17,172	17,220	13,554	11,861	9,636	11,642	13,968	17,653
Total Long-Term Debt	0.00	7,906	9,202	9,959	10,604	12,297	11,312	8,145	9,776	10,969	16,478
Net Debt	0.00	4,228	5,501	6,632	6,520	5,190	5,386	3,051	4,681	9,472	13,004
Capital Expenditures (CapEx)	958	897	1,254	1,324	1,374	996	1,167	1,408	1,713	2,306	2,398
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	882	2,019	1,394	538	1,031	1,190	2,347	2,397	3,027	3,528
Debt-free Net Working Capital (DFNWC)	0.00	3,482	4,601	10,602	10,463	8,769	7,012	8,283	8,738	6,786	7,675
Net Working Capital (NWC)	0.00	3,193	4,221	3,389	3,847	7,512	6,463	6,792	6,872	3,787	6,500
Net Nonoperating Expense (NNE)	95	137	-6.88	-1,016	-1,738	241	-56	-919	149	270	471
Net Nonoperating Obligations (NNO)	0.00	4,229	4,166	6,633	6,521	5,191	5,386	3,051	3,788	9,472	13,004
Total Depreciation and Amortization (D&A)	916	1,061	1,208	1,265	1,787	1,624	1,551	1,577	1,633	1,798	2,156
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	3.38%	7.76%	5.08%	0.00%	3.98%	4.07%	7.17%	6.86%	8.51%	9.42%
Debt-free Net Working Capital to Revenue	0.00%	13.35%	17.69%	38.66%	0.00%	33.87%	24.01%	25.31%	25.00%	19.08%	20.50%
Net Working Capital to Revenue	0.00%	12.24%	16.23%	12.36%	0.00%	29.02%	22.13%	20.76%	19.66%	10.65%	17.36%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$2.27	$3.02	$2.41	$142.90	$0.00	$5.07	$4.36	$5.06	$5.54
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	838.96M	843.39M	799.64M	795.14M	0.00	752.14M	723.90M	683.30M	673.20M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$2.25	$3.01	$2.39	$141.80	$0.00	$5.03	$4.33	$5.02	$5.51
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	838.96M	843.39M	799.64M	795.14M	0.00	752.14M	729.20M	689.50M	677M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	838.96M	843.39M	799.64M	795.14M	0.00	752.14M	690.36M	676.48M	668.25M
Normalized Net Operating Profit after Tax (NOPAT)	887	1,473	2,298	1,873	0.00	1,406	2,600	2,931	3,445	3,733	4,109
Normalized NOPAT Margin	3.81%	5.65%	8.84%	6.83%	0.00%	5.43%	8.90%	8.96%	9.86%	10.49%	10.97%
Pre Tax Income Margin	4.30%	6.54%	7.78%	7.27%	0.00%	5.62%	10.62%	10.58%	11.49%	13.25%	12.83%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	3.05	4.99	6.38	0.00	0.00	4.28	10.85	10.87	11.13	8.47	6.75
NOPAT to Interest Expense	2.06	3.58	6.36	0.00	0.00	3.21	8.35	8.63	8.57	6.20	5.26
EBIT Less CapEx to Interest Expense	0.83	2.81	2.91	0.00	0.00	2.01	7.14	6.78	6.57	4.70	3.79
NOPAT Less CapEx to Interest Expense	-0.17	1.40	2.89	0.00	0.00	0.94	4.64	4.54	4.01	2.43	2.30
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	52.54%	28.35%	24.86%	21.91%	38.15%	61.97%	35.22%	24.25%	31.74%	49.42%	26.44%
Augmented Payout Ratio	52.54%	28.35%	25.01%	53.79%	93.04%	83.35%	68.58%	54.54%	131.58%	91.51%	57.60%

This table displays calculated financial ratios and metrics derived from CRH's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	668,250,818.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	668,250,818.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-0.26
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	0.00%	1.65%	-0.57%	3.82%	2.13%	3.41%	5.72%	5.27%	6.16%	9.09%
EBITDA Growth	0.00%	0.00%	51.81%	12.90%	13.78%	32.84%	-18.94%	7.82%	8.06%	23.12%	29.89%
EBIT Growth	0.00%	0.00%	9,350.00%	14.67%	13.25%	43.44%	-101.06%	4.00%	3.31%	30.11%	-2,000.00%
NOPAT Growth	0.00%	0.00%	2,283.84%	12.21%	4.29%	48.98%	-62.25%	6.65%	14.41%	20.18%	-311.11%
Net Income Growth	0.00%	0.00%	467.74%	8.00%	5.39%	23.73%	-185.96%	1.76%	9.36%	46.26%	-83.67%
EPS Growth	0.00%	0.00%	420.00%	16.05%	9.44%	5.21%	-193.75%	3.19%	12.18%	49.51%	-80.00%
Operating Cash Flow Growth	0.00%	0.00%	-6.11%	-9.12%	-8.89%	12.67%	7.44%	-7.21%	33.98%	6.78%	6.53%
Free Cash Flow Firm Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-78.03%	-254.12%	8.59%	15.81%	12.96%
Invested Capital Growth	0.00%	0.00%	9.87%	9.40%	19.49%	27.21%	15.83%	19.13%	15.90%	19.06%	11.78%
Revenue Q/Q Growth	4.32%	-14.25%	0.00%	47.77%	8.92%	-15.64%	-23.83%	51.07%	8.46%	-14.93%	-21.73%
EBITDA Q/Q Growth	8.68%	-44.14%	0.00%	288.40%	9.53%	-34.78%	-70.79%	416.63%	9.78%	-25.69%	-69.18%
EBIT Q/Q Growth	10.77%	-56.51%	0.00%	879.89%	9.40%	-44.92%	-100.18%	96,400.00%	8.67%	-30.63%	-102.89%
NOPAT Q/Q Growth	10.60%	-53.25%	0.00%	4,020.55%	2.80%	-33.22%	-98.67%	11,540.29%	10.27%	-29.85%	-102.34%
Net Income Q/Q Growth	8.75%	-56.53%	0.00%	1,048.25%	6.11%	-48.96%	-113.82%	1,459.18%	14.04%	-31.73%	-117.36%
EPS Q/Q Growth	11.11%	-46.67%	0.00%	1,075.00%	4.79%	-48.73%	-114.85%	1,393.33%	13.92%	-31.67%	-117.88%
Operating Cash Flow Q/Q Growth	-0.18%	48.56%	0.00%	308.57%	0.07%	83.71%	-124.14%	309.10%	44.48%	46.41%	-121.13%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	53.37%	-228.21%	-50.07%	22.49%	7.24%	15.28%	-38.23%	19.88%
Invested Capital Q/Q Growth	0.53%	-8.12%	0.00%	2.70%	9.80%	-2.19%	5.02%	5.63%	6.82%	0.48%	-1.40%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	37.15%	33.98%	27.66%	38.07%	38.60%	35.63%	27.19%	39.45%	38.93%	35.64%	27.75%
EBITDA Margin	21.63%	14.09%	8.97%	23.58%	23.71%	18.33%	7.03%	24.04%	24.34%	21.26%	8.37%
Operating Margin	17.65%	9.02%	0.43%	18.95%	18.68%	12.45%	0.27%	18.96%	18.80%	14.93%	-0.52%
EBIT Margin	17.66%	8.96%	2.89%	19.18%	19.27%	12.58%	-0.03%	18.87%	18.91%	15.42%	-0.57%
Profit (Net Income) Margin	13.01%	6.60%	1.75%	13.56%	13.21%	7.99%	-1.45%	13.05%	13.72%	11.01%	-2.44%
Tax Burden Percent	76.63%	75.89%	115.15%	75.53%	73.30%	71.83%	67.12%	75.85%	79.07%	81.40%	80.36%
Interest Burden Percent	96.14%	97.04%	52.38%	93.57%	93.53%	88.44%	7,300.00%	91.17%	91.78%	87.74%	533.33%
Effective Tax Rate	24.19%	19.07%	-19.19%	24.81%	28.02%	14.49%	0.00%	24.20%	22.28%	19.31%	0.00%
Return on Invested Capital (ROIC)	0.00%	10.04%	0.64%	17.31%	15.67%	13.12%	0.21%	15.84%	15.11%	12.74%	-0.38%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	8.43%	1.87%	16.32%	15.34%	9.57%	-0.89%	14.55%	14.28%	11.88%	-1.61%
Return on Net Nonoperating Assets (RNNOA)	0.00%	1.48%	0.57%	4.97%	4.99%	2.85%	-0.41%	6.74%	7.04%	5.52%	-0.86%
Return on Equity (ROE)	0.00%	11.51%	1.21%	22.28%	20.66%	15.97%	-0.20%	22.58%	22.15%	18.27%	-1.24%
Cash Return on Invested Capital (CROIC)	0.00%	15.36%	0.00%	0.00%	0.00%	-10.81%	-2.76%	-5.76%	-3.31%	-5.36%	0.54%
Operating Return on Assets (OROA)	0.00%	6.75%	2.22%	14.25%	13.79%	9.13%	-0.02%	13.44%	12.72%	10.60%	-0.39%
Return on Assets (ROA)	0.00%	4.97%	1.34%	10.07%	9.46%	5.80%	-1.06%	9.29%	9.23%	7.57%	-1.69%
Return on Common Equity (ROCE)	0.00%	11.09%	1.17%	21.47%	19.68%	15.25%	-0.19%	21.57%	20.94%	17.24%	-1.17%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	16.07%	15.99%	15.47%	0.00%	15.67%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	1,356	634	33	1,375	1,414	944	13	1,467	1,617	1,135	-27
NOPAT Margin	13.38%	7.30%	0.51%	14.24%	13.44%	10.64%	0.19%	14.37%	14.61%	12.05%	-0.36%
Net Nonoperating Expense Percent (NNEP)	0.75%	1.60%	-1.23%	0.98%	0.33%	3.55%	1.10%	1.29%	0.84%	0.87%	1.23%
Return On Investment Capital (ROIC_SIMPLE)	-	1.92%	-	-	-	2.59%	0.03%	3.76%	3.77%	2.66%	-0.06%
Cost of Revenue to Revenue	62.85%	66.02%	72.34%	61.93%	61.40%	64.37%	72.81%	60.55%	61.07%	64.36%	72.25%
SG&A Expenses to Revenue	19.65%	21.17%	27.35%	20.18%	20.77%	21.79%	27.13%	20.77%	21.12%	21.16%	27.91%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	19.50%	24.96%	27.23%	19.12%	19.92%	23.18%	26.92%	20.49%	20.13%	20.71%	28.26%
Earnings before Interest and Taxes (EBIT)	1,789	778	189	1,852	2,026	1,116	-2.00	1,926	2,093	1,452	-42
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	2,191	1,224	586	2,276	2,493	1,626	475	2,454	2,694	2,002	617
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.83	2.46	2.98	2.48	2.89	2.91	2.82	2.78	3.46	3.49	3.04
Price to Tangible Book Value (P/TBV)	3.57	4.81	6.77	5.48	6.42	6.73	7.06	6.58	9.50	9.45	8.24
Price to Revenue (P/Rev)	0.00	1.46	1.70	1.47	1.79	1.77	1.66	1.71	2.19	2.23	1.85
Price to Earnings (P/E)	0.00	16.11	17.93	15.05	18.14	18.00	18.13	18.78	23.51	22.29	19.14
Dividend Yield	0.00%	1.95%	1.95%	2.71%	2.56%	0.00%	0.00%	0.00%	1.21%	0.00%	0.00%
Earnings Yield	0.00%	6.21%	5.58%	6.64%	5.51%	5.56%	5.52%	5.32%	4.25%	4.49%	5.23%
Enterprise Value to Invested Capital (EV/IC)	1.65	2.23	2.36	2.02	2.25	2.28	2.13	2.11	2.50	2.55	2.28
Enterprise Value to Revenue (EV/Rev)	0.00	1.62	1.97	1.74	2.11	2.07	2.02	2.08	2.59	2.62	2.27
Enterprise Value to EBITDA (EV/EBITDA)	0.00	9.74	11.47	9.70	11.32	10.54	10.53	10.72	13.19	12.87	11.26
Enterprise Value to EBIT (EV/EBIT)	0.00	13.54	15.79	13.22	15.38	14.19	14.49	14.92	18.63	17.94	15.93
Enterprise Value to NOPAT (EV/NOPAT)	0.00	17.58	21.06	17.76	21.35	19.40	19.21	19.59	23.49	23.03	20.62
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	11.29	13.87	12.62	15.91	14.75	14.35	15.31	17.58	17.45	15.26
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	443.85
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.50	0.54	0.61	0.61	0.60	0.61	0.70	0.67	0.76	0.69	0.76
Long-Term Debt to Equity	0.42	0.45	0.47	0.46	0.46	0.48	0.64	0.62	0.60	0.65	0.65
Financial Leverage	0.22	0.18	0.31	0.30	0.33	0.30	0.47	0.46	0.49	0.47	0.53
Leverage Ratio	2.10	2.08	2.13	2.13	2.16	2.21	2.28	2.26	2.30	2.25	2.35
Compound Leverage Factor	2.02	2.02	1.12	2.00	2.02	1.95	166.42	2.06	2.11	1.98	12.52
Debt to Total Capital	33.47%	35.00%	37.92%	37.95%	37.48%	37.94%	41.21%	40.09%	43.16%	40.93%	43.04%
Short-Term Debt to Total Capital	5.46%	5.61%	8.95%	9.31%	8.68%	8.15%	3.83%	2.97%	9.16%	2.72%	5.75%
Long-Term Debt to Total Capital	28.01%	29.39%	28.97%	28.64%	28.80%	29.79%	37.38%	37.12%	34.00%	38.20%	37.29%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	2.59%	2.31%	2.18%	2.10%	3.48%	3.38%	3.26%	3.26%	3.05%	3.42%	3.42%
Common Equity to Total Capital	63.94%	62.69%	59.90%	59.95%	59.03%	58.68%	55.53%	56.65%	53.79%	55.65%	53.53%
Debt to EBITDA	0.00	2.00	2.11	2.09	2.11	2.00	2.28	2.24	2.58	2.32	2.41
Net Debt to EBITDA	0.00	0.80	1.46	1.39	1.50	1.36	1.69	1.73	1.89	1.71	1.92
Long-Term Debt to EBITDA	0.00	1.68	1.61	1.58	1.62	1.57	2.07	2.08	2.03	2.16	2.09
Debt to NOPAT	0.00	3.61	3.86	3.82	3.98	3.68	4.16	4.10	4.59	4.14	4.42
Net Debt to NOPAT	0.00	1.45	2.67	2.54	2.83	2.50	3.08	3.17	3.36	3.05	3.52
Long-Term Debt to NOPAT	0.00	3.03	2.95	2.89	3.06	2.89	3.78	3.80	3.62	3.87	3.83
Altman Z-Score	0.00	2.83	2.94	2.80	2.92	2.89	2.66	2.79	2.88	3.00	2.63
Noncontrolling Interest Sharing Ratio	0.00%	3.70%	3.77%	3.66%	4.75%	4.52%	4.56%	4.46%	5.47%	5.63%	5.79%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.78	1.69	1.37	1.43	1.39	1.37	1.63	1.74	1.45	1.74	1.59
Quick Ratio	1.27	1.08	0.81	0.85	0.88	0.83	0.97	1.08	0.96	1.06	0.83
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	0.00	-2,599	-1,212	-3,977	-5,969	-4,626	-4,291	-3,636	-5,025	-4,027
Operating Cash Flow to CapEx	426.96%	402.49%	0.00%	556.18%	352.97%	147.49%	-108.03%	220.48%	420.04%	423.08%	-107.50%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	-19.54	-7.82	-24.25	-37.31	-25.56	-21.46	-17.40	-22.84	-19.84
Operating Cash Flow to Interest Expense	12.45	26.63	-5.35	9.58	9.06	17.06	-3.64	6.89	9.53	13.25	-3.03
Operating Cash Flow Less CapEx to Interest Expense	9.53	20.01	-3.60	7.86	6.49	5.49	-7.01	3.77	7.26	10.12	-5.86
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.75	0.77	0.74	0.72	0.73	0.73	0.71	0.67	0.69	0.69
Accounts Receivable Turnover	0.00	7.94	7.38	5.83	5.71	7.63	7.20	5.87	5.51	7.49	7.35
Inventory Turnover	0.00	5.42	5.05	5.19	5.18	5.06	4.82	4.86	4.88	4.78	4.86
Fixed Asset Turnover	0.00	1.96	1.90	1.87	1.80	1.81	1.74	1.72	1.64	1.61	1.63
Accounts Payable Turnover	0.00	7.56	8.55	6.59	7.74	7.20	8.38	6.98	7.70	7.39	8.50
Days Sales Outstanding (DSO)	0.00	45.99	49.48	62.63	63.92	47.85	50.67	62.18	66.19	48.73	49.65
Days Inventory Outstanding (DIO)	0.00	67.37	72.33	70.35	70.43	72.18	75.80	75.03	74.82	76.35	75.16
Days Payable Outstanding (DPO)	0.00	48.26	42.68	55.35	47.17	50.72	43.58	52.29	47.38	49.37	42.94
Cash Conversion Cycle (CCC)	0.00	65.09	79.12	77.63	87.18	69.32	82.89	84.92	93.63	75.71	81.86
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	27,656	25,409	29,305	30,097	33,047	32,322	33,944	35,855	38,300	38,482	37,944
Invested Capital Turnover	0.00	1.38	1.25	1.22	1.17	1.23	1.13	1.10	1.03	1.06	1.06
Increase / (Decrease) in Invested Capital	0.00	0.00	2,632	2,587	5,391	6,913	4,639	5,758	5,253	6,160	4,000
Enterprise Value (EV)	45,711	56,643	69,033	60,912	74,494	73,568	72,336	75,568	95,644	98,129	86,504
Market Capitalization	39,821	51,194	59,550	51,487	63,321	62,852	59,510	62,057	80,652	83,650	70,247
Book Value per Share	$28.94	$27.72	$29.10	$30.18	$32.04	$31.80	$31.22	$33.05	$34.65	$35.81	$34.52
Tangible Book Value per Share	$14.82	$14.16	$12.79	$13.67	$14.45	$13.74	$12.47	$13.95	$12.62	$13.21	$12.75
Total Capital	34,043	33,263	33,414	34,569	37,056	36,818	38,028	39,443	43,331	43,131	43,094
Total Debt	11,395	11,642	12,672	13,118	13,890	13,968	15,671	15,813	18,702	17,653	18,549
Total Long-Term Debt	9,535	9,776	9,680	9,900	10,672	10,969	14,213	14,642	14,734	16,478	16,071
Net Debt	5,008	4,681	8,755	8,699	9,881	9,472	11,587	12,225	13,671	13,004	14,782
Capital Expenditures (CapEx)	382	602	-233	267	421	1,851	610	625	474	689	573
Debt-free, Cash-free Net Working Capital (DFCFNWC)	3,262	2,397	3,396	3,848	4,310	3,027	3,636	4,762	4,936	3,528	5,226
Debt-free Net Working Capital (DFNWC)	8,984	8,738	6,704	7,783	7,390	6,786	6,988	7,638	9,224	7,675	8,506
Net Working Capital (NWC)	7,124	6,872	3,712	4,565	4,172	3,787	5,530	6,467	5,256	6,500	6,028
Net Nonoperating Expense (NNE)	38	61	-81	66	25	235	111	135	98	98	153
Net Nonoperating Obligations (NNO)	5,008	3,788	8,563	8,646	9,881	9,472	11,587	12,225	13,671	13,004	13,399
Total Depreciation and Amortization (D&A)	402	446	397	424	467	510	477	528	601	550	659
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	6.86%	9.69%	10.99%	12.18%	8.51%	10.16%	13.10%	13.38%	9.42%	13.73%
Debt-free Net Working Capital to Revenue	0.00%	25.00%	19.12%	22.24%	20.88%	19.08%	19.52%	21.01%	25.00%	20.50%	22.35%
Net Working Capital to Revenue	0.00%	19.66%	10.59%	13.04%	11.79%	10.65%	15.45%	17.79%	14.24%	17.36%	15.84%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.97	$0.16	$1.89	$1.99	$1.02	($0.15)	$1.95	$2.23	$1.51	($0.27)
Adjusted Weighted Average Basic Shares Outstanding	0.00	723.90M	687.80M	685.50M	681.60M	683.30M	676.70M	674.80M	672.30M	673.20M	668.50M
Adjusted Diluted Earnings per Share	$0.00	$0.96	$0.16	$1.88	$1.97	$1.01	($0.15)	$1.94	$2.21	$1.51	($0.27)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	729.20M	693.40M	688.80M	685.50M	689.50M	676.70M	677.70M	675.50M	677M	668.50M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	690.36M	686.68M	682.78M	679.34M	676.48M	676.00M	672.66M	670.27M	668.25M	668.20M
Normalized Net Operating Profit after Tax (NOPAT)	1,344	611	14	1,298	1,350	912	2.80	1,445	1,532	1,068	-8.40
Normalized NOPAT Margin	13.27%	7.04%	0.21%	13.45%	12.84%	10.28%	0.04%	14.16%	13.84%	11.35%	-0.11%
Pre Tax Income Margin	16.98%	8.69%	1.52%	17.95%	18.02%	11.13%	-2.16%	17.21%	17.35%	13.53%	-3.04%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	13.66	8.55	1.42	11.95	12.35	6.98	-0.01	9.63	10.01	6.60	-0.21
NOPAT to Interest Expense	10.35	6.96	0.25	8.87	8.62	5.90	0.07	7.33	7.74	5.16	-0.13
EBIT Less CapEx to Interest Expense	10.74	1.93	3.17	10.23	9.79	-4.59	-3.38	6.51	7.75	3.47	-3.03
NOPAT Less CapEx to Interest Expense	7.43	0.35	2.00	7.15	6.05	-5.67	-3.30	4.21	5.47	2.03	-2.95
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	31.74%	53.81%	43.63%	49.72%	49.42%	29.92%	30.22%	29.35%	26.44%	27.62%
Augmented Payout Ratio	0.00%	131.58%	158.87%	134.61%	116.48%	91.51%	67.18%	66.81%	63.66%	57.60%	60.06%

Financials Breakdown Chart

Key Financial Trends

CRH (NYSE: CRH) shows a multi-year pattern of growing revenue and solid cash generation across the 2023–2025 period covered by the latest quarterly data. The company’s quarterly results demonstrate improving top-line performance, healthy gross margins, and strong operating cash flow, alongside ongoing investing and financing activity that impacts near-term cash balances.

Revenue and gross profit have risen through 2025, with Q4 2025 operating revenue of 9.416B and gross profit of 3.356B, up from 8.685B revenue and 2.951B gross profit in Q4 2023.
Gross margin has remained solid in the mid-30s across the period (e.g., gross profit of 3.356B on 9.416B revenue in Q4 2025).
Net cash from continuing operating activities was 2.915B in Q4 2025, indicating robust cash generation from core operations and an improving cash flow profile versus prior years.
Earnings per share and net income to common shareholders improved in the latest quarter, with diluted EPS of 1.51 and net income to common shareholders of 1.025B in Q4 2025, supporting stronger profitability visibility.
Debt activity in Q4 2025 included issuing about 2.72B of new debt and repayments of about 3.92B, resulting in a net financing cash outflow of about 1.72B (neutral for longer-term liquidity planning).
Dividends paid in Q4 2025 totaled around 224M, reflecting ongoing capital returns to shareholders (neutral to investors assessing cash returns).
Net change in cash and cash equivalents for Q4 2025 was negative by about 141M, signaling near-term cash outflow despite strong CFO.
Q1 2025 included a negative net income to common shareholders of about 94M, highlighting quarterly earnings volatility in the period.
Investing activity remained a cash drag in several quarters, with notable outflows (e.g., Q3 2025 net cash from investing activities around -2.91B and Q4 2025 around -1.34B), which can pressure near-term liquidity but may support growth over the longer term.

05/14/26 06:44 PM ETAI Generated. May Contain Errors.

CRH Financials - Frequently Asked Questions

According to the most recent income statement we have on file, CRH's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

CRH's net income appears to be on an upward trend, with a most recent value of $3.79 billion in 2025, rising from $792.09 million in 2015. The previous period was $3.52 billion in 2024. See CRH's forecast for analyst expectations on what's next for the company.

CRH's total operating income in 2025 was $5.44 billion, based on the following breakdown:

Total Gross Profit: $13.53 billion
Total Operating Expenses: $8.09 billion

Over the last 10 years, CRH's total revenue changed from $23.26 billion in 2015 to $37.45 billion in 2025, a change of 61.0%.

CRH's total liabilities were at $32.85 billion at the end of 2025, a 18.3% increase from 2024, and a 82.1% increase since 2016.

In the past 9 years, CRH's cash and equivalents has ranged from $2.54 billion in 2017 to $9.92 billion in 2019, and is currently $4.10 billion as of their latest financial filing in 2025.

Over the last 10 years, CRH's book value per share changed from 0.00 in 2015 to 35.81 in 2025, a change of 3,581.1%.

Related Companies

Financial statements for NYSE:CRH last updated on 5/3/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CRH (CRH) Financials

Financials Breakdown Chart

Key Financial Trends

CRH Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

CRH (CRH) Financials

Annual Income Statements for CRH

Quarterly Income Statements for CRH

Annual Cash Flow Statements for CRH

Quarterly Cash Flow Statements for CRH

Annual Balance Sheets for CRH

Quarterly Balance Sheets for CRH

Annual Metrics And Ratios for CRH

Quarterly Metrics And Ratios for CRH

Financials Breakdown Chart

Key Financial Trends

CRH Financials - Frequently Asked Questions

When does CRH's fiscal year end?

How has CRH's net income changed over the last 10 years?

What is CRH's operating income?

How has CRH's revenue changed over the last 10 years?

How much debt does CRH have?

How much cash does CRH have?

How has CRH's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools